Summary
At present photocoagulation affords essentially palliative treatment which has been demonstrated to be effective in reducing blindness in diabetic maculopathy and proliferative retinopathy.
It is only by understanding the evolution of diabetic microangiopathy that effective preventative treatment can be found in the future.
Diabetic retino-microangiopathy is a result of the diabetic state which can be divided into a pre-clinical and clinical stage. In the former various changes occur in the retinal capillaries which include dilation, increased blood flow, breakdown of blood-retinal barrier, basement membrane thickening and loss of pericytes. Finally, capillary closure occurs and the condition becomes clinical when microaneurysms form at the edge of non-perfused areas in the retina. Retinal capillary closure appears to result from abnormality both of the vessel wall and the blood flowing through the vessel. The clinical stage of diabetic retinopathy can be sub-divided into (i) mild background retinopathy, (ii) background retinopathy with maculopathy, (iii) proliferative retinopathy-uncomplicated and (iv) proliferative retinopathy with complications (advanced diabetic eye disease). It is essential to concentrate on the pre-clinical stage of diabetic retinopathy when the condition can be arrested or possibly even reversed.
Similar content being viewed by others
References
Almer, L. O., Pandolfii, M. and Nilsson, I. M. 1975. Diabetic retinopathy and the fibrinolytic system. Diabetes 24, 529.
Bensoussan, D., Levy-Toledano S., Passa, P., Caen, J. and Canivet, J. 1975. Platelet hyperaggregation and increased plasma level of Von Willebrand factor in diabetics with retinopathy. Diabetologia 11, 301.
Bern, M. M., 1978. Platelet functions in diabetes mellitus. Diabetes 27, 342.
British Multicentre Controlled Study. 1975. Photocoagulation in treatment of diabetic maculopathy. Lancet ii, 1110.
British Multicentre Controlled Study. 1977. Proliferative diabetic retinopathy: treatment with xenon-arc photocoagulation. Brit. Med. J. i, 739.
British Multicentre Controlled Study. 1979. Photocoagulation for diabetic maculopathy. 2nd interim report. (In press).
Burrows, A. W., Chavin, S. I. and Hockaday, T. D. R. 1978. Plasma-thromboglobulin concentrations in diabetes mellitus. Lancet i, 235.
Christensen, N. J. 1970. A reversible vascular abnormality with diabetic ketosis. Clin. Science 39, 539.
Colwell, J. A., Halushka, P. V., Sarji, K., Levine, J., Sagel, J. and Nair, R. M. G. 1976. Altered platelet function in diabetes mellitus. Diabetes 25, (Suppl. 2), 826.
Colwell, J. A., Sagel, J., Crook, L., Chambers, A. and Laimins, M. 1977. Correlation of platelet aggregation, plasma factor activity and megathrombocytes in diabetic subjects with and without vascular disease. Metabolism 1977, 26, 279.
Cunha-Vaz, J. G., de Abreau, F. J. R., Campos, A. J. and Figo, G. M. 1975. Early breakdown of the blood-retinal barrier in diabetes. Brit. J. Ophthal. 59, 649.
Diabetic Retinopathy Study Research Group. 1976. Preliminary report on effects of photocoagulation. Amer. J. of Ophthal. 81, 383.
Ferguson, J. C., Mackay, N., Philip, J. A. D. and Summer, D. J. 1975. Determination of platelet and fibrinogen half-life with (75Sc) selenomethionine studies in normal and in diabetic subjects. Clin. Science and Molecular Medicine 49, 115.
Griffith, J. D., Dymock, I. W., Davies, E. W. G., Hill, D. W. and Williams, R. 1971. Occurrence and prevalence of diabetic retinopathy in hemochromatosis. Diabetes 20, 766.
Halushka, P. V., Lurie, D., Colwell, J. A. 1977. Increased synthesis of prostaglandin-E-like material by platelets from patients with diabetes mellitus. New Eng. J. Med. 297, 1306.
Harrison, E., Reece, A. H. and Johnson, M. 1978. Decreased vascular prostacyclin in experimental diabetes. Life Sciences 23, 351.
Heath, H., Brigden, W. D., Canever, J. V., Pollock, J., Hunter, P. R., Kelsey, J. and Bloom, A. 1971. Platelet adhesiveness and aggregation in relation to diabetic retinopathy. Diabetologia 7, 708.
Kilo, C., Vogler, N. and Williamson, J. R. 1972. Muscle capillary basement membrane changes related to ageing and to diabetes mellitus. Diabetes 21, 881.
Kohner, E. M., Hamilton, A. M., Saunders, S. J., Sutcliffe, B. A. and Bulpitt, C. J. 1975. The retinal blood flow in diabetes. Diabetologia 11, 27.
Kuwabava, T. and Cogan, D. G. 1963. Retinal vascular patterns. Arch. Ophthal. 69, 492.
Larkins, R. G., Martin, F. I. R. and Tait, B. D. 1978. HLA patterns and diabetic retinopathy. Brit. Med. J. i, 1111.
Little, H. and Sachs, A. H. 1976. Fluorescein Angiograph. Documents Ophthalmolocia, Proceedings series, Vol. 9, ed. by J. J. de Lang, The Hague, W. Junk, p. 473.
McMillan, D. E., Uttermack, N. G. and La Puma, J. 1977. Reduced erythrocyte deformability in diabetes. Diabetes, 26, 369.
Oosterhuis, J. H. and Vink, R. 1967. Perspectives in Ophthalmology. Excerpta Medica, Foundation. p. 115.
Osterby-Hansen, R. and Lundback, K. 1970. Diabetes Mellitus Theory and Practice, ed. by Ellenberg, M. and Rifkin, H. New York, McGraw-Hill, p. 178.
Osterby, R. 1975. Early phases in the development of diabetic glomerulopathy. Acta Medica Scand. (Suppl.) 3, 574.
Papachristodoulou, D. and Heath, H. 1977. Ultrastructural alteration during the development of retinopathy in sucrose-fed and streptozotocin-diabetic rats. Exp. Eye Res. 25, 371.
Patz, A., Schatz, A., Berkow, J. W., Gittelson, A. M. and Ticho, U. 1973. Macular edema — an overlooked complication of diabetic retinopathy. Trans Amer. Accod. Ophthal. and Otolar 77, 34.
Pirart, J. 1977. Diabète et complications dégéneratives. Présentation d’une étude prospective portant sur 4400 cas observés entre 1947 et 1973. Diabète et Metab. 3, 245.
Preston, F. E., Ward, J. D., Marcola, B. H., Porter, N. R., Timperley, W. R. and O’Malley, B. C. 1978. Elevated β-thromboglobulin levels and circulating platelet aggregates in diabetic microangiopathy. Lancet i, 238.
Pyke, D. A. and Tattersall, R. B. 1973. Diabetic retinopathy in identical twins. Diabetes 22, 613.
Riva, C. E., Roberts, W. P., McMeel, J. W. and Ben-Sira, I. 1976. Fluorescein Angiograph, Documents Ophthalmologica, Proceedings series, Vol. 9, ed. by J. J. de Lang, The Hague, W. Junk, p. 113.
Scott, D. J., Dollery, C. T., Hill, D. W., Hodge, J. V. and Fraser, R. 1964. Fluorescein studies of diabetic retinopathy. Brit. Med. J. i, 811.
Siperstein, M. D., Unger, R. H. and Madison, L. L. 1968. Studies of muscle capillary basement membranes in normal subjects, diabetics and prediabetic patients. Clin. Invest. 47, 1973.
Sosula, L. 1974. Capillary radius and wall thickness in normal and diabetic rat retinae. Microvasc. Res. 7, 274.
Speiser, P., Gittelsohn, A. M. and Patz, A. 1968. Studies in diabetic retinopathy. 3. Influence of diabetes on intramural pericytes. Arch. Ophthal. 80, 332.
Walsh, C. H. and Malins, J. M. 1978. Proliferative retinopathy in a patient with diabetes mellitus and idiopathic haemochromatosis. Brit. Med. J. ii, 16.
Waltman, S. R., Oestrich, C., Krupin, T., Hanish, S., Ratzan, S., Santiago, J. and Kilo, C. 1978. Quantitative vitreous fluorophotometry. A sensitive technique for measuring early breakdown of the blood-retinal barrier in young diabetic patients. Diabetes 27, 85.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kohner, E.M. The evolution of diabetic retinopathy. IJMS 148 (Suppl 2), 28–37 (1979). https://doi.org/10.1007/BF02938137
Issue Date:
DOI: https://doi.org/10.1007/BF02938137